...
首页> 外文期刊>Chemical biology and drug design >Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7
【24h】

Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7

机译:基于天然蛙皮肽,ascaphin-8和XT-7肽的有效,无毒的抗菌剂设计

获取原文
获取原文并翻译 | 示例

摘要

The frog skin peptides, ascaphin-8 (GFKDLLKGAAKALVKTVLF.NH2) and XT-7 (GLLGPLLKIAAKVGSNLL.NH2), show broad-spectrum antimicrobial activity but their therapeutic potential is limited by toxicity against mammalian cells. Circular dichroism spectra demonstrate that the peptides adopt an amphipathic alpha-helical conformation in a membrane-mimetic solvent. This study has investigated the cytolytic properties of analogs containing selected amino acid substitutions that increase cationicity while maintaining amphipathicity. Substitutions at Ala(10), Val(14), and Leu(18) in ascaphin-8 by either L-Lys or D-Lys produced peptides that retained antimicrobial activity against the bacteria Escherichia coli and Staphylococcus aureus and the opportunistic yeast pathogen, Candida albicans but showed appreciably reduced toxicities (> 10-fold) against human erythrocytes, HepG2 hepatoma-derived cells, and L929 fibroblasts. The improved therapeutic index of the L-Lys(18) and D-Lys(18) analogs correlated with a decrease in % helicity and in effective hydrophobicity. Substitution of Gly(4) by L-Lys in XT-7 produced an analog with high potency against micro-organisms (MIC <= 25 mu M) but low cytolytic activity against erythrocytes (LD50 > 500 mu M) and this increase in therapeutic index also correlated with decreased helicity and hydrophobicity. Analogs of XT-7 with increased cationicity, containing multiple substitutions by L-Lys, not only displayed increased antimicrobial potencies, particularly against Candida albicans (MIC <= 6 mu M), but also increased hemolytic activities.
机译:青蛙皮肤肽ascaphin-8(GFKDLLKGAAAAKALVKTVLF.NH2)和XT-7(GLLGPLLKIAAKVGSNLL.NH2)具有广谱抗菌活性,但其治疗潜力受到对哺乳动物细胞毒性的限制。圆二色性光谱表明,该肽在膜模拟溶剂中采用两亲性α-螺旋构象。这项研究研究了含有选定氨基酸取代基的类似物的溶细胞特性,这些氨基酸取代基增加了阳离子性,同时又保持了两亲性。 L-Lys或D-Lys取代ascaphin-8中Ala(10),Val(14)和Leu(18)产生的肽段保留了对细菌大肠杆菌和金黄色葡萄球菌以及机会性酵母病原体的抗菌活性,白色念珠菌但显示出对人红细胞,HepG2肝癌衍生细胞和L929成纤维细胞的毒性降低(> 10倍)。 L-Lys(18)和D-Lys(18)类似物的治疗指数提高,与螺旋度降低和有效疏水性降低相关。 L-Lys在XT-7中取代Gly(4)产生了一种对微生物具有高效力的类似物(MIC <= 25μM),但对红细胞的细胞溶解活性却很低(LD50> 500μM),并且这种增加的治疗作用指数还与降低的螺旋度和疏水性相关。具有增加的阳离子性的XT-7类似物,包含被L-Lys多次取代,不仅显示出增强的抗菌功效,尤其是对白色念珠菌(MIC <= 6μM),而且溶血活性也增强。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号